Antiemesis Clinical Practice Guidelines in Oncology

被引：20

作者：

Ettinger, David S.

Armstrong, Debra K. ^{[1
]}

Barbour, Sally

Berger, Michael J. ^{[2
]}

Bierman, Philip J. ^{[3
]}

Bradbury, Bob

Ellis, Georgianna ^{[4
]}

Kirkegaard, Steve ^{[5
]}

Kloth, Dwight D.

Kris, Mark G. ^{[6
]}

Lim, Dean ^{[7
]}

Markiewicz, Michael Anne ^{[8
]}

Nabati, Lida

Nesheiwat, Carli ^{[9
]}

Rugo, Hope S. ^{[10
]}

Sorscher, Steven M. ^{[11
]}

Stucky-Marshal, Lisa ^{[12
]}

Todaro, Barbara

Urba, Susan ^{[13
]}

机构：

[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[2] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[3] Univ Nebraska Med Ctr, Eppley Canc Ctr, Lincoln, NE USA

[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA

[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[6] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[7] City Hope Comprehens Canc Ctr, Duarte, CA USA

[8] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA

[9] Univ Tennessee, Inst Canc, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[10] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[11] Washington Univ, Sch Med, St Louis, MO 63130 USA

[12] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[13] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2009年 / 7卷 / 05期

关键词：

NCCN Clinical Practice Guidelines; antiemesis; nausea and vomiting; chemotherapy-induced; 5-HT3-receptor antagonists; NK-1-receptor antagonists; CHEMOTHERAPY-INDUCED NAUSEA; HIGH-DOSE METOCLOPRAMIDE; MODERATELY EMETOGENIC CHEMOTHERAPY; CISPLATIN-INDUCED EMESIS; 5-HYDROXYTRYPTAMINE-3 RECEPTOR ANTAGONIST; ORAL NK1 ANTAGONIST; DOUBLE-BLIND; ANTICIPATORY NAUSEA; PHASE-III; DELAYED EMESIS;

D O I：

10.6004/jnccn.2009.0039

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：572 / 595

页数：24

共 120 条

[1] METHODOLOGICAL ISSUES IN ANTIEMETIC STUDIES [J].

AAPRO, M .

INVESTIGATIONAL NEW DRUGS, 1993, 11 (04) :243-253

[2]

Aapro Matti S, 2007, Ther Clin Risk Manag, V3, P1009

[3]

AAPRO MS, 1981, CANCER CHEMOTH PHARM, V7, P11

[4] DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE [J].

AAPRO, MS ;

PLEZIA, PM ;

ALBERTS, DS ;

GRAHAM, V ;

JONES, SE ;

SURWIT, EA ;

MOON, TE .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :466-471

[5]

ANDREWS P L R, 1992, European Journal of Cancer, V28A, pS2, DOI 10.1016/0959-8049(92)90628-F

[6]

[Anonymous], 2004, PHYS DESK REFERENCE, V58th

[7]

Audhuy B, 1996, EUR J CANCER, V32A, P807

[8] ADVANCES IN ANTI-EMETIC THERAPY [J].

BAKOWSKI, MT .

CANCER TREATMENT REVIEWS, 1984, 11 (03) :237-256

[9]

Basurto C, 1995, ANN ONCOL, V6, P805

[10] Total body irradiation prior to bone marrow transplantation: Efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis [J].

Belkacemi, Y ;

Ozsahin, M ;

Pene, F ;

Rio, B ;

Sutton, L ;

Laporte, JP ;

Touboul, E ;

Gorin, NC ;

Laugier, A .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (01) :77-82

← 1 2 3 4 5 6 7 8 9 10 →